清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

[An epidemiological survey of current asthma control status in China].

医学 哮喘 流行病学 恶化 中国 儿科 内科学 政治学 法学
作者
Nan Su,Jiangtao Lin,Guoliang Liu,Ping Chen,Xin Zhou,Huanying Wan,Kaisheng Yin,Lijun Ma,Changgui Wu,Jing Li,Chuntao Liu,Hua Xie,Wei Tang,Mao Huang,Yan Chen,Yuanhua Liu,Liqiang Song,Xianliang Chen
出处
期刊:PubMed 卷期号:53 (8): 601-6 被引量:22
链接
标识
摘要

Base on the China asthma and risk factors epidemiologic investigation (CARE study), we analyzed the current status of asthma control in China.With the multi-stage random cluster sampling method, epidemiological survey was performed among Chinese residents who aged over 14 years in 8 provinces (cities) from 2010 to 2011. Detailed clinic data of 2 034 asthma patients were collected via face-to-face home visit . Asthma was diagnosed based upon the history, clinical signs and lung function tests. The SPSS 12.0 was conducted for statistics analysis.This survey found that the prevalence rate of asthma in China was 1.24% (2 034/164 215), including 973 male and 1 061 female patients, with a mean age of (56 ± 18) years old. Consistent with the Global Initiative for Asthma (GINA) guidelines, 40.51% (824/2 034) and 42.58% (866/2 034) of our patients achieved control and partial control, respectively. According to the asthma control test (ACT) estimates, 15.63% (318/2 034) and 49.46% (1 006/2 034) of patients achieved full control (ACT 25) and well control(ACT 20-24), respectively. In the past year, 22.62% (460/2 034) of patients reported hospitalized and 26.99% (549/2 034) of patients reported emergency room visit at least one time due to asthma exacerbation. 61.80% (1 257/2 034) of patients were on daily us of medication. Inhaled corticosteroids (ICS) plus a long-acting β2 agonist (LABA) or solely ICS were used in 6.39% and 14.75% of patients, respectively. Theophylline treatment accounted for 29.11% (592/2 034). Oral glucocorticoid and oral leukotriene modifier (LTRA) treatment accounted for 9.49% (193/2 034) and 3.10% (63/2 034), respectively. According to the survey, 34.51% (702/2 034) of asthma patients reported a history of smoking . The percentage of asthma control in non smoking patients was higher than in smoking patients [43.24% (576/1 332) and 35.33% (248/702), respectively]. Meanwhile, the rates of both hospitalization and emergency due to asthma exacerbation in smoking asthma patients were significantly higher than nonsmoking asthma patients (27.35% and 31.77%, 20.12% and 24.47%, respectively).The situation of asthma control has been improved in China. However, compared with GINA guidelines, there is still a considerable gap. Smoking is one of the crucial factors that affect asthma control.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
woxinyouyou完成签到,获得积分0
16秒前
22秒前
42秒前
50秒前
就是我发布了新的文献求助10
57秒前
liuzhigang完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
爱静静举报孔明不在空城求助涉嫌违规
2分钟前
善学以致用应助无限语海采纳,获得10
2分钟前
2分钟前
Tttttttt完成签到,获得积分10
3分钟前
fighting发布了新的文献求助10
3分钟前
就是我完成签到,获得积分10
3分钟前
淡淡醉波wuliao完成签到 ,获得积分10
3分钟前
4分钟前
无限语海发布了新的文献求助10
4分钟前
5分钟前
无限语海完成签到,获得积分10
5分钟前
5分钟前
春日迟迟2012完成签到 ,获得积分10
5分钟前
6分钟前
6分钟前
紫熊发布了新的文献求助10
6分钟前
7分钟前
7分钟前
紫熊完成签到,获得积分10
7分钟前
Malmever完成签到,获得积分10
7分钟前
7分钟前
8分钟前
方白秋完成签到,获得积分10
8分钟前
lbl发布了新的文献求助10
8分钟前
Richard完成签到 ,获得积分10
8分钟前
小二郎应助lbl采纳,获得10
8分钟前
8分钟前
9分钟前
9分钟前
桐桐应助迅速的不正采纳,获得10
9分钟前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
An Introduction to Geographical and Urban Economics: A Spiky World Book by Charles van Marrewijk, Harry Garretsen, and Steven Brakman 500
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3150617
求助须知:如何正确求助?哪些是违规求助? 2802025
关于积分的说明 7846089
捐赠科研通 2459372
什么是DOI,文献DOI怎么找? 1309219
科研通“疑难数据库(出版商)”最低求助积分说明 628708
版权声明 601757